AmpliTech Group, Inc. (AMPG) - 10-Q Summary
Business Context and Reporting Period
This Quarterly Report on Form 10-Q covers the period ended June 30, 2026. AmpliTech Group, Inc. operates through two primary segments: Manufacturing and Engineering (AmpliTech Inc. and Specialty Microwave), which designs and assembles RF amplifiers and subsystems for satellite, defense, and 5G markets; and Distribution (Spectrum), a global distributor of integrated circuit packaging. The Company is classified as a non-accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2026 | Six Months Ended June 30, 2026 |
|---|---|---|
| Revenue | $8,070,379 | $13,419,825 |
| Gross Profit | $2,254,012 (27.9% margin) | $4,820,878 (35.9% margin) |
| Net Loss | $(3,088,512) | $(4,610,219) |
| Net Loss Per Share (Basic/Diluted) | $(0.12) | $(0.19) |
| Cash and Cash Equivalents | $8,892,838 | $8,892,838 (Balance Sheet) |
| Working Capital | $22,932,180 | $22,932,180 |
| Total Debt (Lease Obligations) | $3,926,224 (Total Lease Liab.) | $3,926,224 |
Note: The Company has no traditional senior debt; liabilities consist primarily of operating and finance lease obligations.
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased 26.8% year-over-year for the quarter and 8.2% for the six-month period. This was primarily due to the absence of one-time revenue from the Titan asset acquisition recognized in the prior year's comparable period.
- Margin Expansion: Despite lower revenue, gross margin improved significantly to 27.9% (Q2) and 35.9% (YTD) from 7.8% and 14.0% respectively in the prior year, driven by a more favorable product mix and the exclusion of lower-margin acquired 5G product sales.
- Expense Growth: Operating expenses increased substantially. Selling, General, and Administrative (SG&A) expenses rose 91.4% for the quarter, and R&D expenses increased 108.6%, driven by higher stock-based compensation, legal fees, amortization, and increased investment in 5G product development and marketing.
- Segment Performance: The Distribution segment remained profitable with a net income of $1.13M for the quarter, while the Manufacturing and Engineering segment reported a net loss of $2.93M.
Guidance, Outlook, and Risks
Recent Developments & Outlook:
- Capital Raises: The Company closed a Rights Offering and a Registered Direct Offering in early 2026, raising significant capital. Subsequently, in July 2026, the Series A Rights closed, generating approximately $21.9 million in gross proceeds.
- Stock Repurchase: On July 7, 2026, the Board authorized a $10 million stock repurchase program over 24 months.
- Titan APA Amendment: In August 2026, the Company amended its asset purchase agreement with Titan due to delivery delays. The aggregate purchase price was reduced from $8.0 million to $7.0 million, with the remaining $2.0 million payable upon successful transfer of the 5G ORAN radio design package.
Risks and Contingencies:
- Internal Controls: Management concluded that disclosure controls and internal controls over financial reporting were not effective as of June 30, 2026, due to material weaknesses including lack of written documentation, ineffective IT general controls, and insufficient segregation of duties.
- Contingent Liability: A $3.0 million contingent liability remains recorded for the second milestone payment of the Titan APA, though the August 2026 amendment reduced the total obligation.
- Liquidity: While the Company currently holds sufficient cash to meet obligations for the next 12 months, it continues to operate at a net loss and relies on equity financing and investment income.
Investor Verification Checklist
- Internal Control Remediation: Verify the progress of the remediation plan for material weaknesses in internal controls over financial reporting.
- Titan APA Milestones: Monitor the status of the 5G ORAN radio design package transfer to determine if the remaining $2.0 million purchase price will be triggered.
- Stock-Based Compensation: Review the impact of significant stock-based compensation grants (including the $5.47M consulting agreement) on future earnings and dilution.
- Series B Rights: Track the exercise rate of the Series B Rights (AMPGZ) expiring November 20, 2026, which could impact future cash flow and share count.
- 5G Product Commercialization: Assess the timeline for the commercialization of the 5G ORAN products and the IoT sprayer, as these are critical to future revenue growth.